Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(17)30205-x

PubMed Identifier: 28619229

Publication URI: http://europepmc.org/abstract/MED/28619229

Type: Journal Article/Review

Volume: 5

Parent Publication: The Lancet. Global health

Issue: 7

ISSN: 2214-109X